Roche Holding AG

Roche Holding AG is a Swiss multinational holding company and one of the world's largest biotech firms, overseeing the operations of F. Hoffmann-La Roche AG, a leading provider of pharmaceuticals and in-vitro diagnostics. Founded in 1896 and headquartered in Basel, it drives innovation across major disease areas including oncology, neuroscience, ophthalmology, infectious diseases, and rare conditions through its two primary divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division develops innovative medicines targeting cancer, haemophilia, and inflammatory diseases, while Diagnostics produces equipment and reagents for clinical research, molecular testing, and patient monitoring. Roche Holding AG maintains a robust research and development pipeline with 76 projects in scope for access-to-medicine initiatives, emphasizing priority areas like hepatitis B and antibacterial-resistant infections, complemented by a portfolio of 118 products including WHO-listed medicines and diagnostics. Notable for wide product registration in low- and middle-income countries and programs like the Global Access Programme serving 89 nations, it plays a pivotal role in global healthcare by integrating diagnostics with therapies to advance patient outcomes and access.